Product Details for: Novolog Mix 70/30 Product Label Grayed out Product Label links indicate that there is no product label available for the product.
Product Label Grayed out Product Label links indicate that there is no product label available for the product.
Product Number | Dosage Form | Route of Administration | Strength | Product Presentation | License Type | Proprietary Name | Marketing Status |
---|---|---|---|---|---|---|---|
001 | Injectable Suspension | Subcutaneous | 700UNITS/10ML (70UNITS/ML); 300UNITS/10ML (30UNITS/ML) | Multi-Dose Vial | 351(a) | Novolog Mix 70/30 | Rx |
002 | Injectable Suspension | Subcutaneous | 210UNITS/3ML (70UNITS/ML); 90UNITS/3ML (30UNITS/ML) | Autoinjector | 351(a) | Novolog Mix 70/30 | Disc |
003 | Injectable Suspension | Subcutaneous | 210UNITS/3ML (70UNITS/ML); 90UNITS/3ML (30UNITS/ML) | Pre-Filled Syringe | 351(a) | Novolog Mix 70/30 | Disc |
004 | Injectable Suspension | Subcutaneous | 210UNITS/3ML (70UNITS/ML); 90UNITS/3ML (30UNITS/ML) | Autoinjector | 351(a) | Novolog Mix 70/30 | Rx |
Proper Name
insulin aspart protamine and insulin aspart
BLA Number
021172
Applicant
Novo Nordisk Inc.
Original Approval Date
November 1, 2001
Date of First Licensure